Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

Exercise 440 Blood Specimen Collection 334 Standard of Care 325 Magnetic Resonance Spectroscopy 259 Radiotherapy 255 Surveys and Questionnaires 245 Radiosurgery 245 Methods 231 Educational Status 231 Early Intervention, Educational 219 Interviews as Topic 149 Practice Guidelines as Topic 147 Biopsy 145 Surgical Procedures, Operative 135 Drug Therapy 133 Control Groups 128 Acupuncture Therapy 124 Therapeutics 110 Cyclophosphamide 103 Palliative Care 101 Counseling 101 Resistance Training 96 Saline Solution 90 Cisplatin 90 Magnetic Resonance Imaging 89 Radiofrequency Ablation 86 Specimen Handling 82 Radiotherapy, Intensity-Modulated 79 Colonoscopy 79 Cognitive Behavioral Therapy 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Isovaleryl-CoA Dehydrogenase × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡